In conclusion, through the above analysis, the differential RBP genes related to pyroptosis in AML were screened, and through the regression analysis of these genes, six biomarkers were obtained, and a risk model associated with metabolism was constructed, which provided a theoretical basis and reference value for the future treatment research and prognosis of AML. The gene discussed is RBP4; the disease is acute myeloid leukemia.